Evidence map›Paper›PMID 18492947›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2008

Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray.

Maia Terashvili, Leon F Tseng, Hsiang-En Wu, Jayashree Narayanan, Lucas M Hart, John R Falck, Phillip F Pratt, David R Harder

Open access · greenAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 89 citations in OpenAlex.

  1. Trial
  2. Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors:Journal of enzyme inhibition and medicinal chemistry · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Oxidized Lipids in Persistent Pain States.Frontiers in pharmacology · 2019
    Review
  13. Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism.Frontiers in molecular neuroscience · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Opioid Analgesia in P450 Gene Cluster Knockout Mice: A Search for Analgesia-Relevant Isoforms.Drug metabolism and disposition: the biological fate of chemicals · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maia TerashviliDepartment of Physiology, Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Leon F Tseng
Hsiang-En Wu
Jayashree Narayanan
Lucas M Hart
John R Falck
Phillip F Pratt
David R Harder
Medical College of Wisconsin · US

Funding

Role of Novel CYP Isoforms in Regulation of Cerebral Blood FlowP01HL059996 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI ROMAN, RICHARD J. · 1999 to 2009
$14.5M
Vascular Signaling by Free RadicalsP01HL068769 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HARDER, DAVID RAE · 2002 to 2006
$7.2M
REGULATING CEREBRAL MICROCIRCULATION BY ASTROCYTESR01HL033833 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HARDER, DAVID RAE · 1985 to 2017
$5.8M
NHLBI NIH HHS P01 HL059996NHLBI NIH HHS P01 HL068769NHLBI NIH HHS P01 HL59996NHLBI NIH HHS P01 HL6876NHLBI NIH HHS R01 HL033833NHLBI NIH HHS R01 HL33833
6 · The paper itself

Abstract

Cytochrome P450 genes catalyze formation of epoxyeicosatrienoic acids (EETs) from arachidonic acid. The effects of 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET microinjected into the ventrolateral periaqueductal gray (vlPAG) on the thermally produced tail-flick response were studied in male Sprague-Dawley rats. 14,15-EET microinjected into vlPAG (3-156 pmol) dose-dependently inhibited the tail-flick response (ED50 = 32.5 pmol). In contrast, 5,6-EET, 8,9-EET, and 11,12-EET at a dose of 156 pmol were not active when injected into the vlPAG. 14,15-EET failed to displace the radiobinding of [3H][D-Ala2,NHPe4, Gly-ol5]enkephalin (mu-opioid receptor ligand) or [3H]naltrindole (delta-opioid receptor ligand) in crude membrane fractions of rat brain. Tail-flick inhibition produced by 14,15-EET from vlPAG was blocked by intra-vlPAG pretreatment with antiserum against beta-endorphin or Met-enkephalin or the mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) or the delta-opioid receptor antagonist naltrindole but not with dynorphin A[1-17] antiserum or the kappa-opioid receptor antagonist nor-binaltorphimine. In addition, tail-flick inhibition produced by 14,15-EET treatment was blocked by intrathecal pretreatment with Met-enkephalin antiserum, naltrindole, or CTOP but not with beta-endorphin antiserum. It is concluded that 1) 14,15-EET itself does not have any affinity for mu- or delta-opioid receptors and 2) 14,15-EET activates beta-endorphin and Met-enkephalin, which subsequently act on mu- and delta-opioid receptors to produce antinociception.

Indexed as

8,11,14-Eicosatrienoic AcidAnalgesicsAnimalsbeta-EndorphinDose-Response Relationship, DrugEnkephalin, MethionineMaleMicroinjectionsPain MeasurementPeriaqueductal GrayRatsRats, Sprague-DawleyReaction Time14,15-epoxy-5,8,11-eicosatrienoic acid8,11,14-Eicosatrienoic AcidAnalgesicsbeta-EndorphinEnkephalin, Methionine

Identifiers

PMID18492947
PMCPMC2567871
OpenAlexW1970131869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.